PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

EMA Launches Priority Medicines Scheme

Takeda and the Digital Healthcare Evolution

Coming Attraction: eyeforpharma Barcelona 2016

Pharm Exec eBooks Available as Apps

Advertisement
Transparency
Rooting Out Pharma Corruption
Transparency International (TI), an anti-corruption organization currently best known for its Corruption Perceptions Index, now has pharma in its sights. Pharm Exec speaks to TI about how it will go about understanding and combating corruption in the sector
/Read more/
Focus
Vaccines 2016: Big Bets for Global Threats
A new wave of technologies supported by innovative business models is transforming the vaccine landscape — and raising the bar on performance. Casey McDonald reports
/Read more/
Calendar
/ MARCH 15–17: EYEFORPHARMA BARCELONA/
BARCELONA, SPAIN
/ APRIL 7–8: GLOBAL TRANSPARENCY REPORTING CONGRESS/
FRANFURT, GERMANY
/ APRIL 18-19: IRT EUROPE – INTERACTIVE RESPONSE TECHNOLOGIES IN CLINICAL TRIALS/
BRUSSELS, BELGIUM
/ APRIL 26–27: MANAGED ACCESS PROGRAMS/
MUNICH, GERMANY
 
Focus
Vaccines: Effective and Cost Effective
Jill Wechsler outlines how both small biotech firms and more leading pharmaceutical companies have expanded vaccine research and production in the past decade, as returns on investment have become more attractive
/Read more/
Emerging Pharma Leaders
Pharm Exec’s Emerging Pharma Leaders 2016 — Nominate Now
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input. Tell us who you think should be included as one of our 2016 Emerging Pharma Leaders. These leaders are vital to the future of the industry, and you can help ensure they get the recognition they deserve. Fill out your nomination today
/Read more/
Europe
A Vicious Circle: The EU Drug Pricing System
A new study spells out the many drug pricing problems in Europe just fine, but fails to address a central access issue—leaving its recommendations frustratingly limited for industry and policymakers
/Read more/
Industry update
//Swedish Orphan Biovitrum AB's Chairman of the Board, Bo Jesper Hansen,  M.D., Ph.D, has informed the Sobi's nomination committee that he will not stand for re-election at the 2016 annual general meeting of shareholders.//Prothena Corporation (Dublin, Ireland) announced the appointment of David B. McNinch as Chief Commercial Officer.//The Cell and Gene Therapy Catapult (London, UK) appointed three new non-executive directors to its Board: Professor Fiona Watt, Dr. Susan Foden, and Dr. Steven Chatfield.//Ashfield Healthcare (Ashby-de-la-Zouch, UK) appointed seven new board members to its UK Board of Directors, effective March 1. They are Anita Osborn (Clinical Services Director), Caroline Wilcher (Recruitment & Talent Acquisition Director), Keith Buckby (Account Director), Prad Mistry (Business Development Director), Karen Bell (Business Development Director), Ian Robinson (Business Development Director) and Paul Frater (Operations Director).//
 
update my profile / advertise with us / print subscribe / digital subscribe / visit pharmexec.com